XML 58 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue Recognition (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jan. 01, 2018
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Effect of LIFO Inventory Liquidation on Income $ 5.0          
Contract assets 55.6 $ 52.6   $ 52.6   $ 0.0
Inventories 167.2 177.2   177.2   207.9
Total current assets 671.5 704.8   704.8   656.6
Deferred tax assets, net 68.7 51.5   51.5   72.0
Assets 1,396.8 1,423.8   1,423.8   1,385.2
Other accrued liabilities 42.0 29.9   29.9   40.5
Total current liabilities 174.6 194.1   194.1   173.1
Total liabilities 640.4 662.8   662.8   638.9
Retained earnings 95.6 123.1   123.1   85.5
Total stockholders' equity 756.4 761.0   761.0   746.3
Total liabilities and stockholders’ equity 1,396.8 1,423.8   1,423.8   1,385.2
Net sales   415.4 $ 356.3 803.4 $ 711.6  
Cost of products sold, excluding depreciation and amortization and other items [1]   343.4 289.6 660.1 552.3  
Operating income   34.7 12.5 71.8 71.8  
Income before income taxes   28.5 6.9 60.1 61.4  
Income tax provision   (7.8) (2.2) (13.7) (20.7)  
Net income   $ 20.7 $ 4.7 $ 46.4 $ 40.7  
Basic earnings per share (in dollars per share)   $ 1.24 $ 0.28 $ 2.78 $ 2.37  
Diluted earnings per share (in dollars per share)   $ 1.22 $ 0.27 $ 2.74 $ 2.34  
Comprehensive income   $ 27.1 $ 5.8 $ 44.5 $ 43.1  
Contract assets       3.0 0.0  
Inventories       (10.0) 1.7  
Accrued liabilities       (10.8) (9.8)  
Net cash provided by (used in) operating activities [2]       84.0 $ 73.1  
Difference between Revenue Guidance in Effect before and after Topic 606 | Accounting Standards Update 2014-09            
Contract assets 55.6 (52.6)   (52.6)    
Inventories (40.7) 32.7   32.7    
Total current assets 14.9 (19.9)   (19.9)    
Deferred tax assets, net (3.3) 3.3   3.3    
Assets 11.6 (16.6)   (16.6)    
Other accrued liabilities 1.5 (3.1)   (3.1)    
Total current liabilities 1.5 (3.1)   (3.1)    
Total liabilities 1.5 (3.1)   (3.1)    
Retained earnings 10.1 (13.5)   (13.5)    
Total stockholders' equity 10.1 (13.5)   (13.5)    
Total liabilities and stockholders’ equity $ 11.6 (16.6)   (16.6)    
Net sales   4.9   3.2    
Cost of products sold, excluding depreciation and amortization and other items   3.4   7.6    
Operating income   1.5   (4.4)    
Income before income taxes   1.5   (4.4)    
Income tax provision   (0.4)   1.0    
Net income   $ 1.1   $ (3.4)    
Basic earnings per share (in dollars per share)   $ 0.07   $ (0.20)    
Diluted earnings per share (in dollars per share)   $ 0.06   $ (0.20)    
Comprehensive income   $ 1.1   $ (3.4)    
Contract assets       (3.0)    
Inventories       8.0    
Accrued liabilities       (1.6)    
Net cash provided by (used in) operating activities       0.0    
Calculated under Revenue Guidance in Effect before Topic 606            
Contract assets   0.0   0.0   0.0
Inventories   209.9   209.9   207.9
Total current assets   684.9   684.9   656.6
Deferred tax assets, net   54.8   54.8   72.0
Assets   1,407.2   1,407.2   1,385.2
Other accrued liabilities   26.8   26.8   40.5
Total current liabilities   191.0   191.0   173.1
Total liabilities   659.7   659.7   638.9
Retained earnings   109.6   109.6   85.5
Total stockholders' equity   747.5   747.5   746.3
Total liabilities and stockholders’ equity   1,407.2   1,407.2   $ 1,385.2
Net sales   420.3   806.6    
Cost of products sold, excluding depreciation and amortization and other items   346.8   667.7    
Operating income   36.2   67.4    
Income before income taxes   30.0   55.7    
Income tax provision   (8.2)   (12.7)    
Net income   $ 21.8   $ 43.0    
Basic earnings per share (in dollars per share)   $ 1.31   $ 2.58    
Diluted earnings per share (in dollars per share)   $ 1.28   $ 2.54    
Comprehensive income   $ 28.2   $ 41.1    
Contract assets       0.0    
Inventories       (2.0)    
Accrued liabilities       (12.4)    
Net cash provided by (used in) operating activities       $ 84.0    
[1] See Note 4 for discussion of our adoption of ASU 2017-12 (as defined in Note 1) and the related reclassification of amounts previously presented in the Statements of Consolidated Income within Unrealized loss (gain) on derivative instruments and now included within Cost of products sold, excluding depreciation and amortization and other items.
[2] See Note 8 for adjustments made to arrive at our Consolidated Balance Sheet as of January 1, 2018 upon adopting ASC 606 (as defined in Note 1).